The industry associations, which are working expeditiously to prepare the rationality profile of the remaining 156 fixed dose combination (FDC) drugs to submit it to the DCGI office for its approval, have started submitting the scientific data of these drugs to the DCGI office.
The details can be read here.
No comments:
Post a Comment